$TKNO
Alpha Teknova, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023041875 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $8.169M $11.53M $7.891M
YoY Change -23.6% -1.39% -21.95%
Cost Of Revenue $6.697M $6.461M $5.781M
YoY Change 13.09% 0.28% 12.67%
Gross Profit $1.472M $5.066M $2.110M
YoY Change -69.14% -3.45% -57.62%
Gross Profit Margin 18.02% 43.95% 26.74%
Selling, General & Admin $8.550M $8.117M $10.00M
YoY Change -3.92% -15.95% 23.94%
% of Gross Profit 580.84% 160.23% 473.98%
Research & Development $1.397M $1.464M $1.870M
YoY Change -27.43% -24.11% 34.53%
% of Gross Profit 94.9% 28.9% 88.63%
Depreciation & Amortization $1.300M $1.000M $893.0K
YoY Change 225.0% 100.0% 14.05%
% of Gross Profit 88.32% 19.74% 42.32%
Operating Expenses $10.23M $12.06M $12.16M
YoY Change -63.09% 1.6% 24.75%
Operating Profit -$8.762M -$6.997M -$10.05M
YoY Change -61.83% 5.6% 110.78%
Interest Expense -$790.0K -$308.0K $128.0K
YoY Change -1228.57% -1200.0% -455.56%
% of Operating Profit
Other Income/Expense, Net -$1.382M -$142.0K $19.00K
YoY Change -1403.77% -607.14% -150.0%
Pretax Income -$10.14M -$7.139M -$14.09M
YoY Change -55.6% 8.2% 191.03%
Income Tax $9.000K $15.00K -$795.0K
% Of Pretax Income
Net Earnings -$10.15M -$7.154M -$13.29M
YoY Change -54.82% 15.33% 264.52%
Net Earnings / Revenue -124.29% -62.06% -168.47%
Basic Earnings Per Share -$0.34 -$0.25
Diluted Earnings Per Share -$0.34 -$0.25 -$0.47
COMMON SHARES
Basic Shares Outstanding 28.34M 28.22M 28.13M
Diluted Shares Outstanding 29.96M 28.27M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.10M $23.71M $42.24M
YoY Change -35.61% -63.37% -51.74%
Cash & Equivalents $32.08M $23.71M $42.24M
Short-Term Investments
Other Short-Term Assets $2.400M $1.741M $2.374M
YoY Change -31.84% 2.35% -2.63%
Inventory $11.47M $12.02M $12.25M
Prepaid Expenses
Receivables $5.160M $4.572M $4.261M
Other Receivables $0.00 $22.00K $22.00K
Total Short-Term Assets $51.08M $43.11M $61.14M
YoY Change -27.1% -46.29% -39.59%
LONG-TERM ASSETS
Property, Plant & Equipment $51.58M $52.86M $71.31M
YoY Change -1.99% 11.86% 139.23%
Goodwill $0.00
YoY Change -100.0%
Intangibles $16.70M $16.98M $17.56M
YoY Change -6.43% -6.33% -6.14%
Long-Term Investments
YoY Change
Other Assets $1.952M $2.030M $2.252M
YoY Change 65.99% 163.98% 1151.11%
Total Long-Term Assets $87.31M $89.44M $91.12M
YoY Change -3.21% -12.25% 39.53%
TOTAL ASSETS
Total Short-Term Assets $51.08M $43.11M $61.14M
Total Long-Term Assets $87.31M $89.44M $91.12M
Total Assets $138.4M $132.5M $152.3M
YoY Change -13.66% -27.25% -8.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.422M $1.081M $2.449M
YoY Change -59.2% -23.93% 8.94%
Accrued Expenses $5.147M $3.658M $8.426M
YoY Change -21.9% -55.66% 53.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $22.16M $0.00
YoY Change
Total Short-Term Liabilities $8.339M $28.65M $10.88M
YoY Change -32.36% 141.48% 40.45%
LONG-TERM LIABILITIES
Long-Term Debt $13.17M $0.00 $21.98M
YoY Change -21.98% -100.0% 85.14%
Other Long-Term Liabilities $16.00M $16.47M $18.30M
YoY Change -6.11% -6.65% 3276.75%
Total Long-Term Liabilities $13.17M $0.00 $40.28M
YoY Change -61.18% -100.0% 224.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.339M $28.65M $10.88M
Total Long-Term Liabilities $13.17M $0.00 $40.28M
Total Liabilities $38.73M $46.34M $52.38M
YoY Change -19.77% -4.9% 124.71%
SHAREHOLDERS EQUITY
Retained Earnings -$81.10M -$71.00M -$55.00M
YoY Change 94.43% 269.06% 629.64%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $99.65M $86.21M $99.89M
YoY Change
Total Liabilities & Shareholders Equity $138.4M $132.5M $152.3M
YoY Change -13.66% -27.25% -8.56%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$10.15M -$7.154M -$13.29M
YoY Change -54.82% 15.33% 264.52%
Depreciation, Depletion And Amortization $1.300M $1.000M $893.0K
YoY Change 225.0% 100.0% 14.05%
Cash From Operating Activities -$4.380M -$3.856M -$8.029M
YoY Change -47.43% -33.95% 160.51%
INVESTING ACTIVITIES
Capital Expenditures $970.0K $2.338M $4.730M
YoY Change -114.74% -121.41% -163.82%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$970.0K -$2.338M -$4.730M
YoY Change -85.26% -78.59% -36.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.63M -180.0K 5.140M
YoY Change 38842.86% -103.57% -514100.0%
NET CHANGE
Cash From Operating Activities -4.380M -3.856M -8.029M
Cash From Investing Activities -970.0K -2.338M -4.730M
Cash From Financing Activities 13.63M -180.0K 5.140M
Net Change In Cash 8.280M -6.374M -7.619M
YoY Change -155.65% -45.62% -27.4%
FREE CASH FLOW
Cash From Operating Activities -$4.380M -$3.856M -$8.029M
Capital Expenditures $970.0K $2.338M $4.730M
Free Cash Flow -$5.350M -$6.194M -$12.76M
YoY Change 205.71% -221.88% -394.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001850902
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40538
dei Entity Registrant Name
EntityRegistrantName
ALPHA TEKNOVA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3368109
dei Entity Address Address Line1
EntityAddressAddressLine1
2451 Bert Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Hollister
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95023
dei City Area Code
CityAreaCode
831
dei Local Phone Number
LocalPhoneNumber
637-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
TKNO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28341302
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11527000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11690000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20648000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22837000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6461000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6443000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13159000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12241000
CY2023Q2 us-gaap Gross Profit
GrossProfit
5066000
CY2022Q2 us-gaap Gross Profit
GrossProfit
5247000
us-gaap Gross Profit
GrossProfit
7489000
us-gaap Gross Profit
GrossProfit
10596000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1464000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1929000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2859000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3942000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2174000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2598000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4517000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4195000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5943000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7059000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13288000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14354000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
573000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
574000
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2195000
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2195000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
12063000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
11873000
us-gaap Operating Expenses
OperatingExpenses
23432000
us-gaap Operating Expenses
OperatingExpenses
23065000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6997000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6626000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15943000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12469000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-308000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
28000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-215000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
166000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
184000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-142000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7139000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6598000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15974000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12454000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-395000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-754000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7154000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6203000
us-gaap Net Income Loss
NetIncomeLoss
-15971000
us-gaap Net Income Loss
NetIncomeLoss
-11700000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28272306
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28272306
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28057801
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28057801
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28227132
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28227132
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28044460
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28044460
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23710000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42236000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4572000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4261000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1050000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2023Q2 us-gaap Inventory Net
InventoryNet
12018000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1741000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2374000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
43113000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
61140000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52861000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17561000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19736000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16983000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2030000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2252000
CY2023Q2 us-gaap Assets
Assets
132548000
CY2022Q4 us-gaap Assets
Assets
152261000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1081000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2449000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3658000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1751000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2223000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
22162000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
28652000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10875000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1219000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1223000
CY2023Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
147000
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
191000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21976000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16322000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18111000
CY2023Q2 us-gaap Liabilities
Liabilities
46340000
CY2022Q4 us-gaap Liabilities
Liabilities
52376000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28341302
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28341302
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28179423
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28179423
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157185000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154891000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70977000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55006000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
86208000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132548000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152261000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
92087000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1070000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
138000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7154000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
86208000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
138548000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
934000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
144000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6203000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
133467000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2080000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
138000
us-gaap Net Income Loss
NetIncomeLoss
-15971000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
86208000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
143203000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
99000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
144000
us-gaap Net Income Loss
NetIncomeLoss
-11700000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
133467000
us-gaap Net Income Loss
NetIncomeLoss
-15971000
us-gaap Net Income Loss
NetIncomeLoss
-11700000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
32000
us-gaap Inventory Write Down
InventoryWriteDown
33000
us-gaap Inventory Write Down
InventoryWriteDown
-8000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2427000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1543000
us-gaap Share Based Compensation
ShareBasedCompensation
2080000
us-gaap Share Based Compensation
ShareBasedCompensation
1721000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-751000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
210000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
99000
tkno Non Cash Lease Expense
NonCashLeaseExpense
31000
tkno Non Cash Lease Expense
NonCashLeaseExpense
181000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2195000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
319000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1176000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1050000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-196000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2507000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1071000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1042000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-737000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-222000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
589000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1362000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-278000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1234000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
626000
tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-44000
tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-40000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11540000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11039000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6650000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16837000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6650000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16837000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5135000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
151000
tkno Payment Of Exit Fee Costs
PaymentOfExitFeeCosts
0
tkno Payment Of Exit Fee Costs
PaymentOfExitFeeCosts
135000
tkno Payment Of Offering Costs
PaymentOfOfferingCosts
-395000
tkno Payment Of Offering Costs
PaymentOfOfferingCosts
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
99000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
138000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
144000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-205000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5092000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18395000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22784000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87518000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23841000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64734000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11527000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11690000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20648000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22837000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Interest Paid Net
InterestPaidNet
630000
us-gaap Interest Paid Net
InterestPaidNet
0
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
920000
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
3668000
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
-1137000
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
20318000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
-1193000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
20587000
us-gaap Nature Of Operations
NatureOfOperations
<p id="i_notes" style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 1. Nature of th</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e Business</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alpha Teknova, Inc. (referred to herein as the Company or Teknova), produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Product offerings include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Teknova supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions, with catalog and custom, made-to-order products.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Teknova manufactures its products at its Hollister, California headquarters and stocks inventory of raw materials, components, and finished goods at that location. The Company ships products directly from its warehouse in Hollister, California.</span></p>
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7200000
us-gaap Net Income Loss
NetIncomeLoss
-16000000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71000000
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
22100000
CY2023Q2 tkno Working Captial
WorkingCaptial
14400000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23700000
tkno Reduction In Workforce Policytext Blocks
ReductionInWorkforcePolicytextBlocks
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reduction in Workforce</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 1, 2023, the Company carried out a reduction in workforce of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> positions, aimed at reducing operating expenses. The Company incurred $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of costs in connection with the reduction in workforce related to severance pay and other termination benefits. The costs associated with the reduction in workforce were recorded in the quarter ended March 31, 2023, in general and administrative expenses.</span></p>
CY2023Q1 tkno Reduction In Workforce Of Positions
ReductionInWorkforceOfPositions
40
CY2023Q1 tkno Severance And Other Related Termination Benefits
SeveranceAndOtherRelatedTerminationBenefits
700000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11527000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11690000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20648000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22837000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1100000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23710000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42236000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
131000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23841000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2023Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8344000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8368000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
108000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
186000
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3566000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3693000
CY2023Q2 us-gaap Inventory Net
InventoryNet
12018000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32107000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32383000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5406000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4520000
CY2023Q2 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
26701000
CY2022Q4 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
27863000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
26160000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
23714000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52861000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q2 us-gaap Depreciation
Depreciation
1000000
us-gaap Depreciation
Depreciation
1900000
CY2022Q2 us-gaap Depreciation
Depreciation
500000
us-gaap Depreciation
Depreciation
1000000
CY2023Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
900000
CY2022Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2200000
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2200000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1600000
CY2023Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
700000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1500000
CY2022Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
700000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1400000
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1293000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2601000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2354000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2413000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2416000
CY2023Q2 tkno Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11917000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22994000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4921000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
18073000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
320000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
22162000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
21976000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5116000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16983000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4543000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y6M
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
575000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1148000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1148000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1148000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
45000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4064000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
308000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2321000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2796000
CY2023Q2 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
655000
CY2022Q4 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
1966000
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
36000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
198000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
646000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1243000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3658000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2022Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
5000000
CY2021Q1 tkno Cash Received Under The Term Loan
CashReceivedUnderTheTermLoan
12000000
CY2022Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
40135000
CY2022Q4 tkno Cash Received Under The Term Loan2
CashReceivedUnderTheTermLoan2
5135000
CY2022Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
5000000
CY2023Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
10000000
CY2023Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
10000000
CY2022Q4 tkno Cash Received Under The Term Loan3
CashReceivedUnderTheTermLoan3
5000000
CY2022Q2 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
If any advance under the Term Loan was prepaid at any time, the prepayment fee was based on the amount being prepaid and an applicable percentage amount, such as 3%, 2%, or 1%, based on the date the prepayment was made after the closing date of the Term Loan.
CY2022Q2 tkno Term Loan Exit Fee Rate
TermLoanExitFeeRate
0.05
tkno Net Revenue Requirement For The Financial Covenant
NetRevenueRequirementForTheFinancialCovenant
42500000
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
22135000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
22135000
CY2023Q2 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
335000
CY2022Q4 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
161000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1070000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
934000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2080000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1721000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.06
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-800000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.061
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7154000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6203000
us-gaap Net Income Loss
NetIncomeLoss
-15971000
us-gaap Net Income Loss
NetIncomeLoss
-11700000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28272306
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28272306
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28057801
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28057801
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28227132
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28227132
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28044460
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28044460
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.25
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.25
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.57
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.57
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.42
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.42

Files In Submission

Name View Source Status
0000950170-23-041875-index-headers.html Edgar Link pending
0000950170-23-041875-index.html Edgar Link pending
0000950170-23-041875.txt Edgar Link pending
0000950170-23-041875-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkno-20230630.htm Edgar Link pending
tkno-20230630.xsd Edgar Link pending
tkno-ex10_1.htm Edgar Link pending
tkno-ex10_2.htm Edgar Link pending
tkno-ex31_1.htm Edgar Link pending
tkno-20230630_pre.xml Edgar Link unprocessable
tkno-20230630_lab.xml Edgar Link unprocessable
tkno-20230630_htm.xml Edgar Link completed
tkno-ex31_2.htm Edgar Link pending
tkno-ex32_1.htm Edgar Link pending
tkno-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tkno-20230630_def.xml Edgar Link unprocessable